|
Volumn 21, Issue 2 B, 2001, Pages 1241-1246
|
Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer
a a a a a a |
Author keywords
Chemotherapy; Early and late stage lung cancer; Indicator of disease progression; Surgical therapy
|
Indexed keywords
CA 125 ANTIGEN;
CARCINOEMBRYONIC ANTIGEN;
TUMOR MARKER;
ADENOCARCINOMA;
ARTICLE;
CANCER CHEMOTHERAPY;
CONTROLLED STUDY;
DISEASE MARKER;
DRUG RESPONSE;
HISTOPATHOLOGY;
HOSPITAL PATIENT;
HUMAN;
HUMAN TISSUE;
LUNG NON SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
METASTASIS;
PRIORITY JOURNAL;
PROGNOSIS;
STATISTICAL ANALYSIS;
ADENOCARCINOMA;
CA-125 ANTIGEN;
CARCINOEMBRYONIC ANTIGEN;
CARCINOMA, LARGE CELL;
CARCINOMA, NON-SMALL-CELL LUNG;
CARCINOMA, SQUAMOUS CELL;
HUMANS;
LUNG NEOPLASMS;
NEOPLASM STAGING;
|
EID: 0035002394
PISSN: 02507005
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (86)
|
References (14)
|